Evidence-Based Reviews

Late-life depression: Focused IPT eases loss and role changes

Author and Disclosure Information

 

References

Adapting ipt for special populations

Resistant depression. Researchers at the University of Pittsburgh are investigating whether adding IPT can achieve remission in depressed older patients who show partial response to a 6-week trial of escitalopram, 10 mg/d. In this ongoing trial, patients with Hamilton Depression Rating Scale scores of 11 to 14 after 6 weeks receive an increased escitalopram dosage (20 mg/d) and are randomly assigned to medication alone or medication plus 16 weeks of IPT.

Cognitive impairment. An unpublished follow-up to the MTLLD study enrolled 116 patients aged ≥70 and used a similar design, except that:

  • patients were not required to have had recurrent depressive episodes
  • paroxetine was used instead of nortriptyline
  • patients with cognitive impairment (Mini-Mental Status Examination scores ?18/30) were included.
Results are being analyzed, but preliminary findings do not show a protective effect for IPT compared with paroxetine.

Cognitive impairment may have interfered with patients’ ability to benefit from traditional IPT. Thus, to improve the quality of life of depressed, cognitively-impaired elders, researchers are involving caregivers (usually a spouse or adult child) in modified forms of IPT couples therapy.6,13-18 A team at the University of Pittsburgh is developing a flexible approach that includes meetings with the patient, the caregiver, or both. Two papers on IPT-CI (for cognitive impairment) are under review.

Related resources

  • International Society for Interpersonal Psychotherapy. Accreditation, training, and research information. www.interpersonalpsychotherapy.org.
  • Stuart S, Robertson M. Interpersonal psychotherapy: a clinician’s guide. London: Edward Arnold Ltd.; 2002.
  • Miller MD, Reynolds CF. Interpersonal psychotherapy. In: Hepple J, Pierce J, Wilkinson P (eds). Psychological therapies with older people. East Sussex, UK: Brunner-Routledge; 2002:103-27.
  • Miller MD, Reynolds CF. Living longer depression-free: a family guide to the recognition, treatment and prevention of depression in later life. Baltimore: Johns Hopkins University Press; 2002.
Drug brand names
  • Escitalopram • Lexapro
  • Nortriptyline • Pamelor
  • Paroxetine • Paxil
Disclosures

Dr. Miller is a consultant to Forest Laboratories and GlaxoSmithKline and is a speaker for Forest Laboratories, GlaxoSmithKline, and Wyeth Pharmaceuticals.

Pages

Recommended Reading

Clinical Capsules
MDedge Psychiatry
Heavy Prenatal Alcohol Linked to Behavioral Ills : In adolescents, skills for academic achievement and social interaction were found to be greatly impaired.
MDedge Psychiatry
Taking Heart History Is Good Idea When Prescribing Stimulants
MDedge Psychiatry
Sleep-Disordered Breathing, ADHD Are Linked in Teens
MDedge Psychiatry
Family Meals Offer Insight Into Eating Disorders
MDedge Psychiatry
Parents of Overweight Children Fail To Accurately Perceive the Problem
MDedge Psychiatry
Ethnicity Seems to Play a Role In Teens' Eating Disorder Risk
MDedge Psychiatry
Program Helps Insomniacs Quit Hypnotics
MDedge Psychiatry
Scans May Predict AD Before Signs Appear : Technique has potential to fast-forward the search for preventive measures that could stall Alzheimer's.
MDedge Psychiatry
Low Plasma β-Amyloid Levels May Be a Marker for Cognitive Decline
MDedge Psychiatry